A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. Perinatal HIV Prevention Trial (Thailand) Investigators.

M, Lallemant; G, Jourdain; Coeur S, Le; S, Kim; S, Koetsawang; AM, Comeau; W, Phoolcharoen; M, Essex; K, McIntosh; V, Vithayasai

doi:10.1056/nejm200010053431401

Public

A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. Perinatal HIV Prevention Trial (Thailand) Investigators.

Shared by NobleBlocks on Oct 1, 2000 • 12:00 AM UTC

Authors:

Lallemant M

Jourdain G

Le Coeur S

Abstract

Background The optimal duration of zidovudine administration to prevent perinatal transmission of human immunodeficiency virus type 1 (HIV-1) should be determined to facilitate its use in areas where resources are limited.Methods We conducted a randomized, double-blind equivalence trial of zidovudin...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!